VEGFA and lung adenocarcinoma: Bevacizumab (Avastin, Roche) is a vascular endothelial growth factor A (VEGFA) monoclonal antibody, which inhibits tumor angiogenesis, and is widely used in colorectal cancer and lung adenocarcinoma.